Yale Psychiatry Grand Rounds: "Lecanemab: The First Disease-Modifying Therapy for Alzheimer's Disease?"

Christopher van Dyck, MD, Professor of Psychiatry, Neurology, and Neuroscience, Yale School of Medicine

"Lecanemab: The First Disease-Modifying Therapy for Alzheimer's Disease?"

Please email Chris Gardner at christopher.gardner@yale.edu for the Zoom link.